Distribution of HPV-16 intratypic variants among women with cervical intraepithelial neoplasia and invasive cervical cancer in Mongolia

Asian Pacific Journal of Cancer Prevention

Volumn 9, Issue 4, 2008, Pages 563-568

  Chimeddorj, Battogtokh ^a   Pak, Chin Young ^a   Damdin, Avirmed ^b   Okamoto, Naoyuki ^c   Miyagi, Yohei ^c  

^a Health Science's University of Mongolia   (Mongolia)

^b National Cancer Center of Mongolia   (Mongolia)

^c KANAGAWA CANCER CENTER   (Japan)

Author keywords

Cancer; Cervical intraepithelial neoplasia; E6 gene; HPV 16 variants; Human papillomavirus

Indexed keywords

ADULT; ARTICLE; CANCER INVASION; CANCER STAGING; CASE CONTROL STUDY; COMPARATIVE STUDY; DEVELOPING COUNTRY; FEMALE; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; IMMUNOHISTOCHEMISTRY; INCIDENCE; ISOLATION AND PURIFICATION; MIDDLE AGED; MONGOLIA; NEEDLE BIOPSY; PATHOGENICITY; PATHOLOGY; PROGNOSIS; RETROSPECTIVE STUDY; STATISTICS; SURVIVAL; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX TUMOR; VIROLOGY; VIRUS INFECTION;

ADULT; BIOPSY, NEEDLE; CASE-CONTROL STUDIES; CERVICAL INTRAEPITHELIAL NEOPLASIA; DEVELOPING COUNTRIES; FEMALE; HUMAN PAPILLOMAVIRUS 16; HUMANS; IMMUNOHISTOCHEMISTRY; INCIDENCE; MIDDLE AGED; MONGOLIA; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PAPILLOMAVIRUS INFECTIONS; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; UTERINE CERVICAL NEOPLASMS; YOUNG ADULT;

EID: 66149092342     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Andersson S, Alemi M, Rylander E, et al (2000). Uneven distribution of HPV 16 E6 prototype and variant (L83V) oncoprotein in cervical neoplastic lesions. Br J Cancer, 83, 307-10.
2. Bernard H-U, Chan S-Y, Manos MM, et al (1994). Identification and assessment of known and novel human papillomaviruses by polymerase chain reaction amplification, restriction fragment length polymorphisms, nucleotide sequence, and phylogenetic algorithms. J Infect Dis, 170, 1077-85.
3. Berumen J, Ordonez RM, Lazcano E, et al (2002). Asian-American variants of human papillomavirus 16 and risk for cervical cancer: a case control study. J Natl Cancer Inst, 93, 1325-30.
4. Bosch FX, Lorincz A, Munoz N, Meijer CJ, Shah KV (2002). The causal relation between human papillomavirus and cervical cancer. J Clin Pathol, 55, 244-65.
5. Chan PK, Lam CW, Cheung TH, et al (2002). Human papillomavirus type 16 intratypic variant infection and risk for cervical neoplasia in southern China. J Infect Dis, 186, 696-700.
6. Choi BS, Kim SS, Yun H, Jang DH, Lee JS (2007). Distinctive distribution of HPV16 E6 D25E and E7 N29S intratypic Asian variants in Korean commercial sex workers. J Med Virol, 79, 426-30.
7. Chimge NO, Tanaka H, Kashiwase K (1997). The HLA system in the population of Mongolia. Tissue Antigens, 49, 477-83.
8. Chimge NO, Batsuuri J (1999). Interethnic genetic differentiation: HLA class I antigens in the population of Mongolia. Am J Hum Biol, 11, 603-18.
9. Dondog B, Clifford GM, Vaccarella S, et al (2008). Human papillomavirus infection in ulaanbaatar, mongolia: a population-based study. Cancer Epidemiol Biomarkers Prev, 17, 1731-8.
10. Grodzki M, Besson G, Clavel C, et al (2006). Increased risk for cervical disease progression of French women infected with the human papillomavirus type 16 E6-350G variant. Cancer Epidemiol Biomarkers Prev, 15, 820-2.
11. Hildesheim A, Schiffman M, Bromley C, et al (2001). Human papillomavirus type 16 variants and risk of cervical cancer. J Natl Cancer Inst, 93, 315-8.
12. Ho L, Chan SY, Burk RD, et al (1993). The genetic drift of human papillomavirus type 16 is a means of reconstructing prehistoric viral spread and the movement of ancient human populations. J Virol, 67, 6413-23.
13. Hu X, Pang T, Guo Z, Mazurenko N, et al (2001). HPV16 E6 gene variations in invasive cervical squamous cell carcinoma and cancer in situ from Russian patients. Br J Cancer, 84, 791-5.
14. Londesborough P, Ho L, Terry G, et al (1996). Human papillomavirus genotype as a predictor of persistence and development of high-grade lesions in women with minor cervical abnormalities. Int J Cancer, 69, 364-8.
15. Matsumoto K, Yasugi T, Nakagawa S, et al (2003). Human papillomavirus type 16 E6 variants and HLA class II alleles among Japanese women with cervical cancer. Int J Cancer, 106, 919-22.
16. Munger K, Baldwin A, Edwards KM, et al (2004). Mechanisms of human papillomavirus-induced oncogenesis. J Virol, 78, 11451-60.
17. Munoz N, Bosch FX, de Sanjose S, et al (2003). Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med, 348, 518-27.
18. Munkhbat B, Sato T, Hagihara M, et al (1997). Molecular analysis of HLA polymorphism in Khoton-Mongolians. Tissue Antigens, 50, 124-34.
19. Nindl I, Rindfleisch K, Lotz B, Schneider A, Durst M (1999). Uniform distribution of HPV 16 E6 and E7 variants in patients with normal histology, cervical intra-epithelial neoplasia and cervical cancer. Int JCancer, 82, 203-7.
20. Picconi MA, Alonio LV, Sichero L, et al (2003). Human papillomavirus type-16 variants in Quechua aboriginals from Argentina. J Med Virol, 69, 546-52.
21. Pista A, Oliveira A, Barateiro A, et al (2007). Molecular variants of human papillomavirus type 16 and 18 and risk for cervical neoplasia in Portugal, J Med Virol, 79, 1889-97.
22. Qiu AD, Wu EQ, Yu XH, et al (2007). HPV prevalence, E6 sequence variation and physical state of HPV16 isolates from patients with cervical cancer in Sichuan, China. Gynecol Oncol, 104, 77-85.
23. Schlecht NF, Kulaga S, Robitaille J et al (2001). Persistent human papillomavirus infection as a predictor of cervical intraepithelial neoplasia. JAMA, 286, 3106-14.
24. Sichero L, Ferreira S, Trottier H et al (2007). High grade cervical lesions are caused preferentially by non-European variants of HPVs 16 and 18. Int J Cancer, 120, 1763-8.
25. Shimada M, Fukushima M, Mukai H, et al (1990). Amplification and specific detection of transforming gene region of human papillomavirus 16,18 and 33 in cervical carcinoma by means of the polymerase chain reaction. Jpn J Cancet Res, 81, 1-5.
26. Tamura K, Dudley J, Nei M, Kumar S (2007). MEGA4: Molecular Evolutionary Genetics Analysis (MEGA) Software Version 4.0. Mol Biol Evolution, 24, 1596-9.
27. Tornesello ML, Duraturo ML, Salatiello I et al (2004). Analysis of human papillomavirus type-16 variants in Italian women with cervical intraepithelial neoplasia and cervical cancer. J Med Virol, 74, 117-26.
28. Tu JJ, Kuhn L, Denny L, Beattie KJ, et al (2006). Molecular variants of human papillomavirus type 16 and risk for cervical neoplasia in South Africa. Int J Gynecol Cancer, 16, 736-42.
29. Villa LL, Sichero L, Rahal P, et al (2000). Molecular variants of human papillomavirus types 16 and 18 preferentially associated with cervical neoplasia. J Gen Virol, 81, 2959-68.
30. Watts KJ, Thompson CH, Cossart YE, Rose BR (2002). Sequence variation and physical state of human papillomavirus type 16 cervical cancer isolates from Australia and New Caledonia. Int J Cancer, 97, 868-74.
31. Woodman CB, Collins S, Winter H, et al (2001). Natural history of cervical human papillomavirus infection in young women: a longitudinal cohort study. Lancet, 357, 1831-6.
32. Xi LF, Koutsky LA, Galloway DA, et al (1997). Genomic variation of human papillomavirus type 16 and risk for high grade cervical intraepithelial neoplasia. J Natl Cancer Inst, 89,796-802.
33. Xi LF, Laura A, Koutsky LA, et al (2007). Risk for high-grade cervical intraepithelial neoplasia associated with variants of human papillomavirus types 16 and 18. Cancer Epidemiol Biomarkers Prev, 16, 4-10.
34. Yamada T, Wheeler CM, Halpern AL, et al (1995). Human papillomavirus type 16 variant lineages in United States populations characterized by nucleotide sequence analysis of the E6, L2, and L1 coding segments. J Virol, 69, 7743-53.
35. Yamada T, Manos MM, Peto J, et al (1997). Human papillomavirus type 16 sequence variations in cervical cancers: a worldwide perspective. J Virol, 71, 2463-72.
36. Zehbe I, Voglino G, Delius H, Wilander E, Tommasino M (1998). Risk of cervical cancer and geographical variations of human papillomavirus 16 E6 polymorphisms. Lancet, 352, 1441-2.
37. Zehbe I, Tommasino M (1999). The biological significance of human papillomavirus type 16 variants for development of cervical neoplasia. Papillomavirus Rep, 10, 105-16.
38. Zehbe I, Tachezy R, Mytilineos J, et al (2001). Human papillomavirus 16 E6 polymorphisms in cervical lesions from different European populations and their correlation with human leukocyte antigen class II haplotypes. Int J Cancer, 94, 711-6.
39. zur Hausen H (2000). Papillomaviruses causing cancer: evasion from host cell control in early events in carcinogenesis. J Natl Cancer Inst, 92, 90-8.